TABLE 3.

Standardized 30‐Day Absolute Risks and average risk ratio for Death and Severe COVID‐19 in different subgroups of psychiatric disorders

	Total number of patients	Events n (%)	30‐day absolute risk (95% CI) †	Standardized average risk ratio (95% CI)
A—Death
No psychiatric disorders ‡	127,281	632 (0.5)	0.5 (0.2–0.8)	Ref.
Schizophrenia spectrum disorders	984	20 (2.0)	1.2 (0.4–2.0)	2.29 (1.36–3.22)
Bipolar disorder	485	8 (1.7)	1.0 (0.3–1.8)	1.87 (1.12–3.12)
Unipolar depression	3764	49 (1.3)	1.1 (0.4–1.6)	1.92 (1.39–2.44)
Other psychiatric disorders	7328	28 (0.4)	0.6 (0.2–1.1)	1.24 (0.75–1.65)
Psychotropic drug redemption §	4479	159 (3.5)	1.1 (0.5–1.8)	2.14 (1.77–2.51)
B—Severe COVID−19
No psychiatric disorders ‡	127,281	1197 (0.9)	0.9 (0.1–1.0)	Ref.
Schizophrenia spectrum disorders	984	39 (4.0)	2.7 (1.9–3.6)	2.82 (1.96–3.67)
Bipolar disorder	485	15 (3.1)	2.2 (1.1–3.3)	2.26 (1.16–3.37)
Unipolar depression	3764	65 (1.7)	1.4 (1.1–1.8)	1.47 (1.11–1.83)
Other psychiatric disorders	7328	52 (0.7)	1.0 (0.7–1.3)	1.04 (0.76–1.33)
Psychotropic drug redemption §	4479	127 (2.8)	1.3 (1.1–1.5)	1.27 (0.91–1.52)

COVID‐19, coronavirus disease 2019; CI, confidence interval.

^†Cox models included age, sex, highest obtained education, income, ischaemic heart disease, congestive heart failure, cerebrovascular disease, chronic kidney disease, hypertension, peripheral artery disease, diabetes, chronic obstructive pulmonary disorder, asthma, substance abuse and malignancy.

^‡Patients without prior psychiatric diagnoses and who did not redeem psychotropic drugs within 90 days prior to index date.

^§Within 90 days prior to index date without having a hospital psychiatric diagnosis.